SEC Stock Data Quick Answer Zhengye Biotechnology Holding Ltd reported Shares Outstanding of 45.67 million shares for fiscal year 2024. Zhengye Biotechnology Holding Ltd Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2024 45.67M +0.0% 2023 45.67M — Zhengye Biotechnology Holding Ltd showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal … Read more
Quick Answer Zhengye Biotechnology Holding Ltd reported Gross Profit of $91.30 million for fiscal year 2024. Zhengye Biotechnology Holding Ltd Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2024 $91.30M -22.3% 2023 $117.51M -20.5% 2022 $147.88M — Zhengye Biotechnology Holding Ltd showed a decrease of -22.3% in Gross Profit compared to the … Read more
Quick Answer Zhengye Biotechnology Holding Ltd reported Operating Income of $16.44 million for fiscal year 2024. Zhengye Biotechnology Holding Ltd Operating Income — Annual History Fiscal Year Operating Income YoY Change 2024 $16.44M -63.5% 2023 $44.99M -31.7% 2022 $65.83M — Zhengye Biotechnology Holding Ltd showed a decrease of -63.5% in Operating Income compared to the … Read more
Quick Answer Zhengye Biotechnology Holding Ltd reported R&D Expense of $1.75 million for fiscal year 2024. Zhengye Biotechnology Holding Ltd R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2024 $1.75M -85.3% 2023 $11.90M -11.3% 2022 $13.42M — Zhengye Biotechnology Holding Ltd showed a decrease of -85.3% in R&D Expense compared to the … Read more
Quick Answer Zhengye Biotechnology Holding Ltd reported Stockholders Equity of $283.96 million for fiscal year 2024. Zhengye Biotechnology Holding Ltd Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2024 $283.96M +4.1% 2023 $272.85M -23.5% 2022 $356.87M +11.9% 2021 $318.84M — Zhengye Biotechnology Holding Ltd showed an increase of +4.1% in Stockholders Equity … Read more
Quick Answer Zhengye Biotechnology Holding Ltd reported Cash and Equivalents of $2.55 million for fiscal year 2024. Zhengye Biotechnology Holding Ltd Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2024 $2.55M -83.1% 2023 $15.07M — Zhengye Biotechnology Holding Ltd showed a decrease of -83.1% in Cash and Equivalents compared to … Read more
Quick Answer Zhengye Biotechnology Holding Ltd reported Total Assets of $493.25 million for fiscal year 2024. Zhengye Biotechnology Holding Ltd Total Assets — Annual History Fiscal Year Total Assets YoY Change 2024 $493.25M -1.3% 2023 $499.89M — Zhengye Biotechnology Holding Ltd showed a decrease of -1.3% in Total Assets compared to the prior fiscal year. … Read more
Quick Answer Zhengye Biotechnology Holding Ltd reported Diluted EPS of $0.25 per share for fiscal year 2024. Zhengye Biotechnology Holding Ltd Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2024 $0.25 -63.8% 2023 $0.69 -32.4% 2022 $1.02 — Zhengye Biotechnology Holding Ltd showed a decrease of -63.8% in Diluted EPS compared to … Read more
Quick Answer Zhengye Biotechnology Holding Ltd reported Net Income of $11.31 million for fiscal year 2024. Zhengye Biotechnology Holding Ltd Net Income — Annual History Fiscal Year Net Income YoY Change 2024 $11.31M -64.0% 2023 $31.46M -32.7% 2022 $46.73M — Zhengye Biotechnology Holding Ltd showed a decrease of -64.0% in Net Income compared to the … Read more
Quick Answer Zhengye Biotechnology Holding Ltd reported Total Revenue of $186.36 million for fiscal year 2024. Zhengye Biotechnology Holding Ltd Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2024 $186.36M -12.0% 2023 $211.65M -18.7% 2022 $260.27M — Zhengye Biotechnology Holding Ltd showed a decrease of -12.0% in Total Revenue compared to the … Read more